Total Payments
$6,180
2023 Payments
$319.34
Companies
19
Transactions
393
Medicare Patients
2,061
Medicare Billing
$255,786
Payment Breakdown by Category
Food & Beverage$6,153 (99.6%)
Gifts$26.56 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,153 | 392 | 99.6% |
| Gift | $26.56 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,387 | 91 | $0 (2023) |
| AbbVie Inc. | $1,206 | 74 | $0 (2023) |
| Janssen Biotech, Inc. | $1,025 | 82 | $0 (2023) |
| PFIZER INC. | $783.81 | 38 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $532.60 | 39 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $286.06 | 12 | $0 (2017) |
| Celgene Corporation | $170.55 | 9 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $117.94 | 8 | $0 (2018) |
| Boston Scientific Corporation | $105.04 | 3 | $0 (2019) |
| Takeda Pharmaceuticals America, Inc. | $94.24 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $319.34 | 18 | Janssen Biotech, Inc. ($86.50) |
| 2022 | $838.46 | 47 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($200.02) |
| 2021 | $898.92 | 62 | PFIZER INC. ($266.54) |
| 2020 | $687.76 | 46 | PFIZER INC. ($210.15) |
| 2019 | $1,215 | 79 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($328.89) |
| 2018 | $1,105 | 75 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($538.73) |
| 2017 | $1,116 | 66 | AbbVie, Inc. ($351.39) |
All Payment Transactions
393 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/20/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/16/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Immunology | ||||||
| 05/11/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: Neuroscience | ||||||
| 05/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/15/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Immunology | ||||||
| 04/06/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: Neuroscience | ||||||
| 03/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Gastroenterology | ||||||
| 03/22/2023 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| 03/18/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Immunology | ||||||
| 03/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Gastroenterology | ||||||
| 02/11/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Immunology | ||||||
| 02/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: Neuroscience | ||||||
| 01/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/24/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Gastroenterology | ||||||
| 01/20/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Immunology | ||||||
| 01/10/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.88 | General |
| Category: Neuroscience | ||||||
| 01/05/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Gastroenterology | ||||||
| 12/14/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Neuroscience | ||||||
| 12/14/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Neuroscience | ||||||
| 12/10/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 12/05/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Gastroenterology | ||||||
| 12/01/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 286 | 301 | $192,525 | $29,485 |
| 2022 | 9 | 578 | 623 | $375,500 | $74,817 |
| 2021 | 10 | 680 | 761 | $429,450 | $87,433 |
| 2020 | 10 | 517 | 554 | $346,950 | $64,051 |
Total Patients
2,061
Total Services
2,239
Medicare Billing
$255,786
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 87 | 87 | $78,300 | $8,860 | 11.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 26 | 26 | $26,000 | $4,818 | 18.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $29,725 | $4,274 | 14.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $7,200 | $3,968 | 55.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $27,000 | $3,297 | 12.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $13,500 | $1,670 | 12.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 17 | 17 | $9,350 | $1,521 | 16.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 29 | $1,450 | $1,078 | 74.4% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 131 | 131 | $117,900 | $17,520 | 14.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 61 | $13,725 | $8,663 | 63.1% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Office | 2022 | 25 | 25 | $22,500 | $8,175 | 36.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 61 | 61 | $44,225 | $7,782 | 17.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 108 | 112 | $56,000 | $7,595 | 13.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 28 | 28 | $28,000 | $5,353 | 19.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 20 | 20 | $10,000 | $3,824 | 38.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 34 | 38 | $20,900 | $3,738 | 17.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 17 | 17 | $12,325 | $3,718 | 30.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 19 | 19 | $13,775 | $3,370 | 24.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 36 | 36 | $32,400 | $2,888 | 8.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 39 | 75 | $3,750 | $2,192 | 58.5% |
| 45384 | Removal of tissue abnormalities, tumors, or polyps of large bowel by hot biopsy forceps, using a flexible endoscope | Facility | 2021 | 149 | 149 | $134,100 | $22,690 | 16.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 79 | 81 | $18,225 | $12,345 | 67.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 149 | 156 | $78,000 | $10,327 | 13.2% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 74 | 74 | $53,650 | $9,596 | 17.9% |
| 45384 | Removal of tissue abnormalities, tumors, or polyps of large bowel by hot biopsy forceps, using a flexible endoscope | Office | 2021 | 18 | 18 | $16,200 | $6,031 | 37.2% |
About Dr. Mark Anderson, M.D
Dr. Mark Anderson, M.D is a Gastroenterology healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538132170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Anderson, M.D has received a total of $6,180 in payments from pharmaceutical and medical device companies, with $319.34 received in 2023. These payments were reported across 393 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($6,153).
As a Medicare-enrolled provider, Anderson has provided services to 2,061 Medicare beneficiaries, totaling 2,239 services with total Medicare billing of $255,786. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Montgomery, AL
- Active Since 02/13/2006
- Last Updated 03/15/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1538132170
Products in Payments
- XIFAXAN (Drug) $1,190
- STELARA (Biological) $869.32
- XELJANZ (Drug) $783.81
- Humira (Biological) $645.57
- HUMIRA (Biological) $381.87
- UCERIS (Drug) $261.35
- ENTYVIO (Biological) $259.37
- Entyvio (Biological) $158.13
- REMICADE (Biological) $155.77
- ZEPOSIA (Drug) $153.27
- APRISO (Drug) $123.32
- Trulance (Drug) $117.94
- DIFICID (Drug) $90.18
- Amitiza (Drug) $82.10
- LINZESS (Drug) $80.28
- SPYSCOPE (Device) $76.24
- Donnatal (Drug) $62.01
- VIBERZI (Drug) $56.91
- Dexilant (Drug) $51.62
- RINVOQ (Biological) $51.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Montgomery
Dr. Viplove Senadhi, D.o, D.O
Gastroenterology — Payments: $375,271
Gastroenterology $375,271
Dr. Freeha Khan, M.d, M.D
Gastroenterology — Payments: $46,875
Gastroenterology $46,875
Dr. Howard Zhang, M.d, M.D
Gastroenterology — Payments: $9,227
Gastroenterology $9,227
Dr. Nina Nelson-Garrett, M.d, M.D
Gastroenterology — Payments: $8,488
Gastroenterology $8,488
Thomas Schussler, M.d, M.D
Gastroenterology — Payments: $6,981
Gastroenterology $6,981
Heather Echols, Md, MD
Gastroenterology — Payments: $6,333
Gastroenterology $6,333